Chargement en cours...

Pharmacokinetics, Safety, and Tolerability of Lasmiditan in Pediatric Patients with Migraine

INTRODUCTION: Lasmiditan is a selective serotonin (5-HT1F) receptor agonist approved in the US for the acute treatment ofmigraine in adults. This phase I, open-label, two-cohort study assessed the pharmacokinetics (PK), safety, and tolerability of lasmiditan in patients with migraine aged 6 to <...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:Clin Pharmacokinet
Auteurs principaux: Tsai, Max, Nery, Emel Serap Monkul, Kerr, Lisa, Khanna, Rashna, Komori, Mika, Dennehy, Ellen B., Wilbraham, Darren, Winner, Paul
Format: Artigo
Langue:Inglês
Publié: Springer International Publishing 2021
Sujets:
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC8195962/
https://ncbi.nlm.nih.gov/pubmed/33565026
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s40262-020-00966-z
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!